Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model
Thomas Mercher, … , Olivier A. Bernard, D. Gary Gilliland
Thomas Mercher, … , Olivier A. Bernard, D. Gary Gilliland
Published March 16, 2009
Citation Information: J Clin Invest. 2009;119(4):852-864. https://doi.org/10.1172/JCI35901.
View: Text | PDF
Research Article Oncology

The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model

  • Text
  • PDF
Abstract

Acute megakaryoblastic leukemia (AMKL) is a form of acute myeloid leukemia (AML) associated with a poor prognosis. The genetics and pathophysiology of AMKL are not well understood. We generated a knockin mouse model of the one twenty-two–megakaryocytic acute leukemia (OTT-MAL) fusion oncogene that results from the t(1;22)(p13;q13) translocation specifically associated with a subtype of pediatric AMKL. We report here that OTT-MAL expression deregulated transcriptional activity of the canonical Notch signaling pathway transcription factor recombination signal binding protein for immunoglobulin κ J region (RBPJ) and caused abnormal fetal megakaryopoiesis. Furthermore, cooperation between OTT-MAL and an activating mutation of the thrombopoietin receptor myeloproliferative leukemia virus oncogene (MPL) efficiently induced a short-latency AMKL that recapitulated all the features of human AMKL, including megakaryoblast hyperproliferation and maturation block, thrombocytopenia, organomegaly, and extensive fibrosis. Our results establish that concomitant activation of RBPJ (Notch signaling) and MPL (cytokine signaling) transforms cells of the megakaryocytic lineage and suggest that specific targeting of these pathways could be of therapeutic value for human AMKL.

Authors

Thomas Mercher, Glen D. Raffel, Sandra A. Moore, Melanie G. Cornejo, Dominique Baudry-Bluteau, Nicolas Cagnard, Jonathan L. Jesneck, Yana Pikman, Dana Cullen, Ifor R. Williams, Koichi Akashi, Hirokazu Shigematsu, Jean-Pierre Bourquin, Marco Giovannini, William Vainchenker, Ross L. Levine, Benjamin H. Lee, Olivier A. Bernard, D. Gary Gilliland

×

Figure 3

OTT-MAL activates RBPJ-mediated transcriptional activity.

Options: View larger image (or click on image) Download as PowerPoint
OTT-MAL activates RBPJ-mediated transcriptional activity.
(A) Immunoprec...
(A) Immunoprecipitation analyses in 293T cells transfected with OTT-MAL and OTT-MALΔRRM mutant show interaction between OTT-MAL and RBPJ through the N-terminal region of OTT (see B). STAT5 antibody was used as a nonspecific control. (B) Schematic representation of OTT, MAL, OTT-MAL (OM), and OM mutants. (C) 293T cells were transfected with the indicated constructs. Luciferase assays were performed 48 hours after transfection. Mean ± SD light intensity of 3 independent experiments is shown. Inset, expression analysis of the different constructs in 293T cells by Western blot (anti-HA antibody). (D) TNR mice (GFP under the control of RBPJ-responsive elements) were crossed to OM animals, and GFP fluorescence intensity was analyzed in lineage-negative hematopoietic progenitors from WT, TNR, and OM+TNR mice. (E) RNA was extracted from lineage-negative cells of OM and WT littermate control animals and analyzed by quantitative RT-PCR for Notch target genes compared with Gapdh. Mean ± SD of 3 independent experiments is shown. (F) Immunoprecipitation analyses of 6133 cell lysate indicate interaction between RBPJ and OTT-MAL in AMKL cells. (G) Chromatin immunoprecipitation assays were performed with 6133 cells and Ba/F3 cells and analyzed by quantitative PCR using primers surrounding a RBPJ binding site in the endogenous promoter of the Hes1 gene. Mean ± SD of triplicate quantitative PCR from a representative experiment are shown. (H) 6133 cells were transduced with a retrovirus expressing a dnRBPJ mutant. GFP-positive cells were flow sorted, and proliferation was monitored using trypan blue exclusion assay. Mean ± SD relative to noninfected cells is represented (n = 3).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts